MAYA MARTINEZ-DAVIS was appointed global head of the oncology franchise of Merck KGaA. She will be based in Billerica, Mass., and will report to Rehan Verjee, chief marketing and strategy officer of the healthcare business sector. Martinez-Davis was a senior executive with Pfizer for more than a decade. Prior to her tenure with Pfizer, she... […]
ED SAUTER was named director of the breast surgery program at the Hartford HealthCare Cancer Institute. He will lead the breast surgery programs at each of the institute’s five cancer centers. Sauter previously served as director of the Cancer Treatment and Prevention Center at the University of Texas Health Science Center at Tyler. Prior to... […]
ERIC DISHMAN was named director of the Precision Medicine Initiative Cohort Program at NIH. Dishman will lead NIH’s effort to build the PMI longitudinal research study of one million or more volunteers. Dishman was a member of the working group that helped develop the design for the study. He succeeds Josephine Briggs, who served as... […]
SCHULMAN IRB was selected as the national IRB for the Cancer MoonShot 2020 program. “We are honored to be a part of this momentous initiative,” said Michael Woods, president and CEO of Schulman IRB. “Schulman’s IRB members and staff are excited to partner with leaders in the oncology field in these landmark studies, and we... […]
IBM announced plans to launch its first Watson Health European Center of Excellence in Milan near the Human Technopole Italy 2040 research campus, supporting the government of Italy’s initiative to establish an international hub for the advancement of genomics, big data, aging, and nutrition. The center is part of a long-term collaboration between IBM and... […]
RARECYTE Inc. signed a Cooperative Research and Development Agreement with NCI for a three-year collaboration to investigate the use of RareCyte’s technology to identify, characterize, capture and analyze rare immune cell populations as well as individual circulating tumor cells derived from preclinical and clinical studies conducted by the NCI. The specific goals of the CRADA... […]
DANA-FARBER CANCER INSTITUTE and the ONTARIO INSTITUTE FOR CANCER RESEARCH joined the OHSU Knight Cancer Institute and Intel Corporation‘s Collaborative Cancer Cloud system, a distributed precision medicine analytics platform. The Collaborative Cancer Cloud works to determine how genes interact to drive disease in individual patients. The system is designed for secure, aggregated computation across distributed... […]
PAUL BUSHDID joined Southern Research to lead its Developmental & Reproductive Toxicology program. Previously, Bushdid spent 13 years at GlaxoSmithKline, where he headed an Investigative Developmental Toxicology group, where his work focused on agents that can cause birth defects or halt pregnancies. Bushdid’s team was also involved in DART assessments of traditional Chinese medicines, study... […]
TIMOTHY EBERLEIN was elected chairman of the board of directors of the National Comprehensive Cancer Network.
ANNE JADWIN, vice president of nursing services and chief nursing officer at Fox Chase Cancer Center, has been recognized with the 2016 Outstanding Nurse Award from the Delta Tau Chapter-at-Large: Sigma Theta Tau International Honor Society of Nursing. The award will be announced at the 2016 induction ceremony for the Delta Tau Chapter-at-Large April 10... […]
